Le Lézard
Classified in: Science and technology
Subjects: Product/Service, Award

MGI Research Names Icertis Top Contract Lifecycle Management Vendor


Icertis, the global leader in AI-powered contract intelligence, received the highest 360-degree rating from MGI Research in the firm's latest Contract Lifecycle Management (CLM) Buyer's Guide, earning the top position among CLM vendors.

More than 20 companies were evaluated against criteria such as market visibility and growth, innovation, potential to disrupt the market, ability to deliver value, and demonstrated success via customer and partner references. In addition to earning the highest composite score, Icertis outpaced competitors in solution strength, go-to-market approach, overall strategy, and ability to handle complexity and volume, reaffirming the company's standing as the AI-powered contract intelligence platform of choice for large-scale enterprises.

"2023 was a landmark year for Icertis in terms of performance and growth. The company remains one of the leading CLM options for complex, multi-national enterprises looking to address their contract management challenges," said Andrew Dailey, Managing Director, MGI Research. "Icertis continues to advance its business through greater product verticalization and deeper partnerships and is one of the few vendors with a demonstrable base of buy-side and sell-side customers across a diverse set of industries."

"More than 30 percent of the Fortune 100 trust Icertis to transform their enterprises using contract data and AI because we understand the challenges they face in today's market and offer a flexible, innovative platform that integrates with their core business solutions," said Deanna Lanier, Chief Strategy Officer, Icertis. "Our long-term strategy at Icertis is not just a vision. It's backed by our proven ability to drive strategic outcomes for customers and align the Icertis Contract Intelligence platform with roadmaps from fellow leaders like Microsoft and SAP who are shaping the technology landscape of the future."

Contract data reflects every relationship between a business and its suppliers, partners, and customers. By structuring contract data and connecting it to core business operations, the Icertis Contract Intelligence platform leverages the power of AI and the Icertis Data Lake of more than 10 million contracts to grow revenue, control costs, mitigate risk, and ensure compliance for the world's largest enterprises. As a result of its customer experience, positive growth trajectory, and continued delivery of AI innovation with contracts, Icertis was recently recognized as a Customers' Choice vendor in the 2024 Gartner® Peer Insightstm Voice of the Customer report, one of the 2024 Financial Times' Fastest Growing Companies in the Americas, and a winner in the 2024 Artificial Intelligence Excellence Awards.

About Icertis

Icertis is the global leader in AI-powered contract intelligence. The Icertis platform revolutionizes contract management, equipping customers with powerful insights and automation to grow revenue, control costs, mitigate risk, and ensure compliance - the pillars of business success. Today, 30% of the Fortune 100 trust Icertis to realize the full intent of millions of commercial agreements in 90+ countries.


These press releases may also interest you

at 18:05
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 10:15
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

at 06:47
After tens of thousands of NYC children were turned away from "Summer Rising," New York City's popular, free summer enrichment program, Brains & Motion launched a campaign offering camps at NYU for a small fraction of the up-to-$1400 per week price...



News published on and distributed by: